Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis (Q34978960)

5 August 2017

6 references

19 June 2019

30 June 2019

14 September 2019

20 November 2019

19 December 2019

4 August 2020

0 references

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis (English)

1 reference

ORCID Public Data File 2021

5 August 2017

0 references

1 reference

14 September 2019

1 reference

20 November 2019

1 reference

19 December 2019

1 reference

1 reference

4 August 2020

1 reference

author name string

Zuowei Wang

1

1 reference

5 August 2017

Zezhi Li

2

1 reference

5 August 2017

Keming Gao

3

1 reference

5 August 2017

Yiru Fang

4

1 reference

5 August 2017

24 December 2014

7 references

5 August 2017

19 June 2019

30 June 2019

14 September 2019

20 November 2019

19 December 2019

4 August 2020

7 references

5 August 2017

19 June 2019

30 June 2019

14 September 2019

20 November 2019

19 December 2019

4 August 2020

14

1 reference

5 August 2017

366

1 reference

Creative Commons Attribution

5 August 2017

6 references

19 June 2019

30 June 2019

14 September 2019

20 November 2019

19 December 2019

4 August 2020

0 references

https://scigraph.springernature.com/pub.10.1186/1471-244x-14-5

0 references

cites work

Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

The relationship between neurotrophins and bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Treatment of bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association of the Brain-derived Neurotrophic Factor Gene and Clinical Features of Bipolar Disorder in Korea

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Population genetic study of the brain-derived neurotrophic factor (BDNF) gene

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment Implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Family, twin, and adoption studies of bipolar disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

On estimating the relation between blood group and disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Neuroplasticity and cellular resilience in mood disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genetics of bipolar disorder.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Characterization of single-nucleotide polymorphisms in coding regions of human genes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Chromosome Workshop: chromosomes 11, 14, and 15.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Combining evidence from clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Natural history of multiple sclerosis: a unifying concept

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Depression in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Major depression in multiple sclerosis: a population-based perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

'Restricting choices and limiting independence': social and economic impact of multiple sclerosis upon households by level of disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Correlates of cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis--results of the βPlus observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Major depression and quality of life in individuals with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Structural brain abnormalities in multiple sclerosis patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Multiple sclerosis relapses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Multiple sclerosis and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The Goldman Consensus statement on depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Relationship between coping, cognitive dysfunction and depression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

A review of psychological correlates of adjustment in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Multiple sclerosis: empirical literature for the clinical health psychologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Cognitive-behavioral therapy: what benefits can it offer people with multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Contributing factors to depressed mood in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Review of intervention studies on depression in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Assessing the potential for outcome reporting bias in a review: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Telephone-administered psychotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Searching multiple databases for systematic reviews: added value or diminishing returns?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Searching CINAHL did not add value to clinical questions posed in NICE guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Psychiatric disorder in the general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Suicide among Danes with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Suicide and multiple sclerosis: an epidemiological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: the IAPT experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Combined pharmacotherapy and psychological treatment for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

A review about the impact of multiple sclerosis on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Telephone-administered psychotherapy for depression in MS patients: moderating role of social support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

Cognitive predictors of response to treatment for depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Undiagnosed bipolar disorder in patients treated for major depression in China

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

[An association study between GRIN1, BDNF genes and bipolar disorder].

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

BDNF gene is a risk factor for schizophrenia in a Scottish population.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Neuronal plasticity and survival in mood disorders.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297385

Coping and psychological adjustment among people with multiple sclerosis

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-14-5

[An association study of brain-derived neurotrophic factor gene polymorphism in bipolar disorders]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25539739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Molecular genetics of bipolar disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25539739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25539739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-244X-14-5

1 reference

5 August 2017

1 reference

5 August 2017

1 reference